View in EDS

Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.

Saved in:
Bibliographic Details
Title: Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.
Authors: Boguniewicz M; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.; Division of Allergy and Immunology, National Jewish Health, Denver, CO, USA., Sher LD; Peninsula Research Associates, Rolling Hills Estates, CA, USA., Paller AS; Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Arkwright PD; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK., Yoshihara S; Department of Pediatrics, School of Medicine, Dokkyo Medical University, Tochigi, Japan., Smith Begolka W; National Eczema Association, Novato, CA, USA., Chen Z; Department of Pediatrics, School of Medicine, Dokkyo Medical University, Tochigi, Japan., Shah P; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Rodríguez Marco A; Sanofi, Madrid, Spain.
Source: Journal of asthma and allergy [J Asthma Allergy] 2026 May 19; Vol. 19, pp. 590176. Date of Electronic Publication: 2026 May 19 (Print Publication: 2026).
Publication Type: Journal Article; Comment
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101543450 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6965 (Print) Linking ISSN: 11786965 NLM ISO Abbreviation: J Asthma Allergy Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42266404
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Boguniewicz+M%22">Boguniewicz M</searchLink>; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.; Division of Allergy and Immunology, National Jewish Health, Denver, CO, USA.<br /><searchLink fieldCode="AU" term="%22Sher+LD%22">Sher LD</searchLink>; Peninsula Research Associates, Rolling Hills Estates, CA, USA.<br /><searchLink fieldCode="AU" term="%22Paller+AS%22">Paller AS</searchLink>; Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Arkwright+PD%22">Arkwright PD</searchLink>; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Yoshihara+S%22">Yoshihara S</searchLink>; Department of Pediatrics, School of Medicine, Dokkyo Medical University, Tochigi, Japan.<br /><searchLink fieldCode="AU" term="%22Smith+Begolka+W%22">Smith Begolka W</searchLink>; National Eczema Association, Novato, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Z%22">Chen Z</searchLink>; Department of Pediatrics, School of Medicine, Dokkyo Medical University, Tochigi, Japan.<br /><searchLink fieldCode="AU" term="%22Shah+P%22">Shah P</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rodríguez+Marco+A%22">Rodríguez Marco A</searchLink>; Sanofi, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101543450%22">Journal of asthma and allergy</searchLink> [J Asthma Allergy] 2026 May 19; Vol. 19, pp. 590176. <i>Date of Electronic Publication: </i>2026 May 19 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101543450 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1178-6965 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211786965%22">11786965 </searchLink><i>NLM ISO Abbreviation: </i>J Asthma Allergy <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42266404
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/JAA.S590176
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 590176
    Titles:
      – TitleFull: Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Boguniewicz M
      – PersonEntity:
          Name:
            NameFull: Sher LD
      – PersonEntity:
          Name:
            NameFull: Paller AS
      – PersonEntity:
          Name:
            NameFull: Arkwright PD
      – PersonEntity:
          Name:
            NameFull: Yoshihara S
      – PersonEntity:
          Name:
            NameFull: Smith Begolka W
      – PersonEntity:
          Name:
            NameFull: Chen Z
      – PersonEntity:
          Name:
            NameFull: Shah P
      – PersonEntity:
          Name:
            NameFull: Rodríguez Marco A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 05
              Text: 2026 May 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1178-6965
          Numbering:
            – Type: volume
              Value: 19
          Titles:
            – TitleFull: Journal of asthma and allergy
              Type: main
ResultId 1